Group 1 - The core viewpoint of the article is that Dongwu Securities has given a "buy" rating to Jiahe Meikang (688246.SH) with a latest price of 37.07 yuan, highlighting its position as one of the earliest companies in China engaged in the research and industrialization of medical information software [2] - Jiahe Meikang has significant backing from major investors, including China Life and Alibaba, which enhances its credibility and market position [2] - The ongoing policy push for the continuous upgrade of hospital electronic medical record systems is expected to benefit companies like Jiahe Meikang, indicating a favorable market environment [2]